Kura Oncology competitors

Kura Oncology's competitors include Endocyte, Agios Pharmaceuticals, Epizyme and Avacta Group
Add company...
Kura Oncology
Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Endocyte
Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Epizyme
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
Avacta Group
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics
Founding Date
Founding Date
2007
Founding Date
1995
Founding Date
2008
Founding Date
2007
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
West Lafayette, US HQ
Indianapolis, US
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
Thorp Arch Estate, GB HQ
London, GB
Employees
Employees
30
Employees
76
Employees
38233% increase
Employees
112
Employees
87
Valuation ($)
Valuation ($)
607.8 m
Valuation ($)
958.4 m
Valuation ($)
5.6 b
Valuation ($)
1 b
Valuation ($)
60.4 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
513
Twitter followers
984
Twitter followers
313

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$70k (FY, 2017)
Revenue (est.)
$43m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
£1.3m (FY, 2017)
Net income
Net income
($35.4m) (FY, 2017)
Net income
($55.1m) (FY, 2017)
Net income
($314.7m) (FY, 2017)
Net income
($134.3m) (FY, 2017)
Net income
(£6.6m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 41m
Total funding raised
N/A
Total funding raised
$ 51.5m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Endocyte
HQ
West Lafayette, US
Employees
76

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

View company
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
382↑ 33% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
Epizyme
HQ
Cambridge, US
Employees
112

Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.

View company
Avacta Group
HQ
Thorp Arch Estate, GB
Employees
87

Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics

View company